Intelligent surgical marker
Inventors
Assignees
New Jersey Institute of Technology
Publication Number
US-12295799-B2
Publication Date
2025-05-13
Expiration Date
2042-06-23
Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
Surgical marker systems and methods for delineating a lesion margin of a subject are provided. An example system includes a handheld probe device configured to capture an optical coherence tomography (OCT) image and a processor coupled to a memory. The handheld probe device includes a handheld probe including a fiber-optic probe assembly and a marker assembly. The processor is configured to: segment, by a neural network, each pixels of the OCT into different tissue-type categories; generate one or more feature vectors based at least in part on the segmented pixels; determine, by a one-class classifier, a boundary location in the OCT image between a normal tissue and an abnormal tissue of the tissue structure; and control the marker assembly to selectively create a visible label on a tissue location of the subject, the tissue location corresponding to the boundary location.
Core Innovation
The invention provides a surgical marker system and methods for delineating a lesion margin of a subject, including a handheld probe device configured to capture an optical coherence tomography (OCT) image and a processor coupled to a memory. The handheld probe device comprises a fiber-optic probe assembly to direct and collect light for OCT imaging, and a marker assembly to create a visible label on the lesion margin. The processor uses a neural network to segment each pixel of the OCT image into different tissue-type categories, generates feature vectors from these segmented pixels, applies a one-class classifier to determine a boundary location between normal and abnormal tissue, and controls the marker assembly to create a visible label at the boundary location.
This invention addresses the clinical need for quantitative, objective, and data-driven delineation of lesion margins to guide surgeons in performing more accurate tissue excision, particularly for procedures such as Mohs micrographic surgery (MMS). Conventional margin determination relies on qualitative and subjective visual assessment, which depends on the surgeon's experience and can result in less accurate outcomes. The system provides contemporaneous and concurrent margin detection and marking, overcoming the limitations of conventional imaging modalities that lack sufficient spatial resolution to identify microscopic pathological features.
The system integrates high-quality OCT imaging with a lightweight, manually and/or automatically scanned probe capable of imaging uneven tissue surfaces. Artificial intelligence algorithms, including a deep convolutional neural network (such as U-Net) for tissue segmentation and a one-class classifier (such as SVM) for detecting anomalies, are employed for automatic tissue classification and tumor margin detection. The system further provides a mechanism for registering tumor margins back to the patient by directly marking the identified boundary on the tissue surface, facilitating precise surgical excision based on objective data.
Claims Coverage
The patent contains two independent claims that define the system and method for delineating a lesion margin using OCT imaging, AI-driven tissue classification, and a marking mechanism.
Surgical marker system for margin delineation with OCT and AI
A surgical marker system includes: - A handheld probe device configured to capture OCT images providing in-depth cross-sectional tissue views. - A fiber-optic probe assembly that directs light to and collects light from a region of interest for image acquisition. - A marker assembly that can create a visible label on the lesion margin. - A processor with memory configured to segment each pixel of the OCT image into tissue-type categories via a neural network, generate feature vectors from the segmented pixels, use a one-class classifier to determine a boundary between normal and abnormal tissue structures, and control the marker assembly to create a visible label on the corresponding tissue location.
Method for delineating lesion margin using OCT image analysis and marking
A method involving: 1. Capturing an OCT image of a tissue structure beneath a tissue surface. 2. Segmenting each pixel into tissue-type categories using a neural network. 3. Generating feature vectors based on segmented pixels. 4. Determining a boundary location between normal and abnormal tissue using a one-class classifier based on the feature vectors. 5. Controlling a marker assembly to create a visible label on the tissue location corresponding to the determined boundary.
The inventive features cover a comprehensive surgical marker system and corresponding method that integrate OCT imaging, neural network-based tissue segmentation, feature vector analysis, one-class classification for anomaly detection, and in situ boundary marking, all aimed at accurate lesion margin delineation.
Stated Advantages
Enables quantitative, objective, and data-driven delineation of lesion margins for more accurate surgical removal compared to conventional qualitative and subjective methods.
Provides contemporaneous and concurrent margin detection and marking, leading to more accurate tissue excision (especially at the first stage) and reduced surgical time.
Utilizes a single fiber OCT instrument with in vivo imaging and machine learning-based tumor boundary assessment and marking, resulting in more precise tumor margin detection.
Allows automatic, robust, and comprehensive tissue classification and characterization, overcoming challenges of speckle noise, depth-dependent decay, and the need for expert readers with specialized training.
Enables marking of margins directly on tissue by registering image-derived spatial locations back to the patient, facilitating precise surgical excision.
Documented Applications
Guidance for Mohs micrographic surgery (MMS) to delineate lesion margins for skin cancers and assist in surgical excision.
Delineation of lesion margins for other types of surgeries and procedures requiring tissue boundary identification.
Objective marking of margins for nonmelanoma skin cancers (NMSCs) to aid treatment and reduce subjective visual interpretation.
Interested in licensing this patent?